Pakistan yesterday tested its longest-range missile yet, capable of carrying a nuclear warhead and hitting targets deep inside neighboring India, a defense ministry official said.
The official, who did not want to be named, said the test was "100 percent successful." The official did not disclose where the test was conducted.
"It can carry both conventional and unconventional warheads," he said.
The surface-to-surface Shaheen 2 missile has a range of 2,000km. Pakistan's previous longest-range missile was the Ghouri, tested in 1997, which has a range of 1,300km.
Pakistan's Foreign Ministry spokesman Masood Khan said on Monday that "neighbors and concerned countries," including India, would be informed in advance of the test -- which comes despite peace moves in recent months between the South Asian rivals.
"We have to test these missiles from time to time," he told a press conference on Monday.
Domestically, the test appeared aimed at allaying concerns that President Pervez Musharraf was rolling back the country's nuclear program under international pressure, after Pakistan's top nuclear scientist admitted spreading sensitive technology to other countries.
Musharraf has vowed to retain Pakistan's nuclear deterrent against larger neighbor India. Pakistan conducted a nuclear test in 1998.
Talat Masood, a former army general and military analyst, said the missile test demonstrated Pakistan's advances in missile technology and would help ease criticism at home in the wake of the nuclear proliferation scandal.
FAKE NEWS? ‘When the government demands the press become a state mouthpiece under the threat of punishment, something has gone very wrong,’ a civic group said The top US broadcast regulator on Saturday threatened media outlets over negative coverage of the Middle East war, after US President Donald Trump slammed critical headlines from the “Fake News Media.” The US president since his first term has derided mainstream media as “fake news” and has sued major outlets over what he sees as unfair coverage. Brendan Carr, head of the US Federal Communications Commission — which oversees the nation’s radio, television and Internet media — said broadcasters risked losing their licenses over news coverage. “The law is clear. Broadcasters must operate in the public interest, and they will
INFLUTENTIAL THEORIST: Habermas was particularly critical of the ‘limited interest’ shown by German politicians in ‘shaping a politically effective Europe Jurgen Habermas, whose work on communication, rationality and sociology made him one of the world’s most influential philosophers and a key intellectual figure in his native Germany, has died. He was 96. Habermas’ publisher, Suhrkamp, said he died on Saturday in Starnberg, near Munich. Habermas frequently weighed in on political matters over several decades. His extensive writing crossed the boundaries of academic and philosophical disciplines, providing a vision of modern society and social interaction. His best-known works included the two-volume Theory of Communicative Action. Habermas, who was 15 at the time of Nazi Germany’s defeat, later recalled the dawn of
The Chinese public maintains relatively warm sentiments toward Taiwan and strongly prefers non-military paths to improving cross-strait relations, a recent survey conducted by the Atlanta, Georgia-based Carter Center and Emory University showed. The “China Pulse” research project, which polled 2,506 adults between Oct. 27 last year and Jan. 1 this year, found that 86 percent of respondents support strengthening cultural ties, while 81 percent favor deepening economic interaction. The report, co-authored by political scientists at Emory University and advisors at the Carter Center, indicates that the Chinese public views Taiwan’s importance through a lens of shared history and culture rather than geopolitical
Cannabis-based medicines have shown little evidence of effectiveness for treating most mental health and substance-use disorders, according to a large review of past studies published in a major medical journal on Monday. Medical use of cannabinoids has been expanding, including in the US, Canada and Australia, where many patients report using cannabis products to manage conditions such as anxiety, post-traumatic stress disorder and sleep problems. Researchers reviewed data from 54 randomized clinical trials conducted between 1980 and May last year involving 2,477 participants for their analysis published in The Lancet. The studies assessed cannabinoids as a primary treatment for mental disorders or substance-use
RSS